EARNINGS PER COMMON SHARE - Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially issuable shares (in shares)	13,081	18,994	12,686	14,803
0.599% senior subordinated convertible notes due in August 2024 (the 2024 Notes) | Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential shares issued if converted (in shares)			4,000
1.25% senior subordinated convertible notes due in May 2027 (the 2027 Notes) | Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential shares issued if converted (in shares)			4,400
Issuances under equity incentive plans
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially issuable shares (in shares)	8,716	10,659	8,321	10,438
Common stock issuable under the Company’s convertible debt
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially issuable shares (in shares)	4,365	8,335	4,365	4,365